Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study

Henry Zakumumpa, Helen Byomire Ndagije, Joanitah Atuhaire, Julius Mayengo, Francis Odipiyo, Kiguba Ronald

Open source

DOI
10.1186/s12879-025-11592-0
Published
2025-11-03
Container
BMC Infectious Diseases
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12879-025-11592-0,
  title = {Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study},
  author = {Henry Zakumumpa and Helen Byomire Ndagije and Joanitah Atuhaire and Julius Mayengo and Francis Odipiyo and Kiguba Ronald},
  year = {2025},
  journal = {BMC Infectious Diseases},
  doi = {10.1186/s12879-025-11592-0},
  url = {https://doi.org/10.1186/s12879-025-11592-0}
}

RIS

TY  - JOUR
TI  - Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study
AU  - Henry Zakumumpa
AU  - Helen Byomire Ndagije
AU  - Joanitah Atuhaire
AU  - Julius Mayengo
AU  - Francis Odipiyo
AU  - Kiguba Ronald
PY  - 2025
JO  - BMC Infectious Diseases
DO  - 10.1186/s12879-025-11592-0
UR  - https://doi.org/10.1186/s12879-025-11592-0
ER  - 

APA

Zakumumpa, H., Ndagije, H. B., Atuhaire, J., Mayengo, J., Odipiyo, F., & Ronald, K. (2025). Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-025-11592-0

Source records